Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-021821
Filing Date
2013-03-18
Accepted
2013-03-18 17:24:12
Documents
1
Period of Report
2013-03-14

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 6959
  Complete submission text file 0001104659-13-021821.txt   8513
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Riker Lauren Bullaro (Reporting) CIK: 0001545439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 13699031